Normalized names for clinical drugs: RxNorm at 6 years

By S. J. Nelson, Kelly Zeng, John Kilbourne, Tammy Powell, Robin Moore. J. Am. Medical Informatics Assoc., 2011

458 citations recorded by the source corpus.

OBJECTIVE In the 6 years since the National Library of Medicine began monthly releases of RxNorm, RxNorm has become a central resource for communicating about clinical drugs and supporting interoperation between drug vocabularies. MATERIALS AND METHODS Built on the idea of a normalized name for a medication at a given level of abstraction, RxNorm provides a set of names and relationships based on 11 different external source vocabularies. The standard model enables decision support to take place for a variety of uses at the appropriate level of abstraction. With the incorporation of National Drug File Reference Terminology (NDF-RT) from the Veterans Administration, even more sophisticated decision support has become possible. DISCUSSION While related products such as RxTerms, RxNav, MyMedicationList, and MyRxPad have been recognized as helpful for various uses, tasks such as identifying exactly what is and is not on the market remain a challenge.

Subfields: Artificial Intelligence, Information Systems, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/a4b229788f87a41d25b2de2ab4ce0de3db4c950c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Artificial Intelligence

  1. Monica Agrawal
  2. David A. Sontag
  3. A. Levy
  4. Arvind Satyanarayan
  5. Mihaela van der Schaar
  6. Ahmed M. Alaa
  7. Yonatan Belinkov
  8. Alexander M. Rush

In Information Systems

  1. David A. Sontag

In Molecular Biology

  1. A. Levy
  2. David A. Sontag
  3. Monica Agrawal
  4. Arvind Satyanarayan
  5. Marinka Zitnik

Citations in the corpus